That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
2:15 PMYahoo Finance
Is Amgen stock priced right against its Peers?
6:52 AMYahoo Finance
Amgen’s acquired Sjögren’s drug a Phase III hit
6:02 AMYahoo Finance
45 ETFs add to Amgen (AMGN) Holdings on Tuesday
4:02 PMYahoo Finance
Amgen, in a buy Zone, unveils highly Anticipated Novartis-Rivaling Sjogren's data
11:10 AMYahoo Finance
Amgen (AMGN) stock looks Cheap Based on future cash Flow
10:24 AMYahoo Finance
Amgen reports Phase 3 dazodalibep Trial Meets Primary endpoint in Sjögren’s disease
8:00 AMYahoo Finance
AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE
6:04 AMYahoo Finance
iShares Biotechnology ETF (IBB) adds Gilead and Amgen on Nov. 9
1:17 PMYahoo Finance
Amgen vs. Regeneron: Higher dividends now or bigger growth Later?
12:05 AMYahoo Finance
Amgen’s Repatha shows cost-effectiveness in cardiovascular study
5:08 PMYahoo Finance
What does Amgen (AMGN) mean for Heart Attack risk after new Repatha data?
4:00 PMYahoo Finance
NEW DATA AT AHA 2026 DEMONSTRATES THE VALUE OF TREATMENT WITH REPATHA® EARLIER IN THE CARDIOVASCULAR RISK CONTINUUM
Here is what to know beyond why Amgen Inc. (AMGN) is a trending stock
6:03 AMYahoo Finance
ETFs are net sellers of Amgen (AMGN) on Nov. 5
5:47 PMYahoo Finance
Amgen's new drug could mean fewer shots for obesity patients
9:09 AMYahoo Finance
Amgen’s dividend has Grown 800% since 2011. Here’s what it pays today
6:01 AMYahoo Finance
57 ETFs add to Amgen (AMGN) Holdings on Wednesday
2:13 PMYahoo Finance
Amgen (AMGN) takes Aim at rare disease delays while expanding RNA Drug Hunt
12:41 PMYahoo Finance
What are Amgen investors betting on?
11:25 AMYahoo Finance
Amgen vs. Pfizer: Which Healthcare stock is a better buy for 2027?
9:00 AMYahoo Finance
REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN a LARGE REAL-WORLD STUDY